A clinical and histological evaluation of conservative pulpal therapy in human teeth.
Three intermediary base materials, a zinc oxide-eugenol (Cavitec) and two calcium hydroxide liners (Life and Dycal), were selected at random for use as a base beneath amalgam or composite restorations on humans following complete caries removal. Life and Dycal, selected at random, were also used as direct and indirect pulp capping agents as clinically indicated. Clinical evaluations of signs and symptoms were made before treatment and at one-week, six-month, and one-year intervals following treatment. Histological evaluations were performed on three complete caries removal teeth and 18 direct pulp capping teeth six months following treatment. No significant differences in clinical symptomatology resulted between the materials in the complete caries removal group or the indirect and direct pulp capping groups.
Fitzgerald
M
M
University of Michigan, School of Dentistry, Department of Cariology and General Dentistry, Ann Arbor 48109-1078.
Heys
R J
RJ
D000328:Adult; D002126:Calcium Hydroxide / Q000494:pharmacology; D016009:Chi-Square Distribution; D003731:Dental Caries / Q000601:surgery; D003736:Dental Cavity Lining; D003764:Dental Materials / Q000494:pharmacology; D003782:Dental Pulp / Q000187:drug effects; D003785:Dental Pulp Capping / Q000379:methods*; D003807:Dentin Sensitivity; D004338:Drug Combinations; D005054:Eugenol / Q000494:pharmacology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008903:Minerals / Q000494:pharmacology; D015034:Zinc Oxide / Q000494:pharmacology; D015035:Zinc Oxide-Eugenol Cement / Q000494:pharmacology
D003764:Dental Materials; D004338:Drug Combinations; D008903:Minerals; D015035:Zinc Oxide-Eugenol Cement; C028995:eugenol, zinc oxide dental cavity lining; D005054:Eugenol; C025702:Dycal; C040408:Life (dental material); D002126:Calcium Hydroxide; D015034:Zinc Oxide